Elsevier

Neuroscience

Volume 8, Issue 3, March 1983, Pages 495-505
Neuroscience

Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat

https://doi.org/10.1016/0306-4522(83)90195-1Get rights and content

Abstract

The ventral tegmental area of the rat brain has been shown to possess high densities of neurotensin- and dopamine-containing neuronal perikarya. We recently demonstrated that microinjection of neurotensin into the ventral tegmental area produces behavioral hyperactivity similar to amphetamine-induced increase in exploratory behaviors, but lacking stereotypies. In this study, we report that the threshold dose for neurotensin-induced hyperactivity is 0.10–0.25 μg neurotensin/side. Either intracerebroventricular injection of haloperidol (5.0 μg/lateral ventricle) or destruction of the mesolimbic dopamine system by 6-hydroxydopamine abolishes the behavioral hyperactivity produced by intraventral tegmental injection of neurotensin (2.5 μg/side). Using high pressure liquid chromatography with electrochemical detection, we show that neurotensin injection into the ventral tegmental area increases the concentration of dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the nucleus accumbens and olfactory tubercles, but not in the striatum. This effect is especially profound in the nucleus accumbens where the threshold dose is less than 0.025 μg/side. The ratio of 3,4-dihydroxyphenylacetic acid to dopamine increased in the nucleus accumbens and olfactory tubercles in a dosedependent fashion (0.025 μg–2.50 μg/side). Neurotensin-induced behavioral hyperactivity correlates positively with neurotensin-induced changes in the ratio of 3,4-dihydroxyphenylacetic acid to dopamine.

This study indicates that neurotensin acts in the ventral tegmental area to activate the mesolimbic dopamine system. Further, this activation produces behavioral hyperactivity characterized by an increase in exploratory behaviors. The fact that both immunoreactive neurotensin and neurotensin receptors are found in high concentration in the ventral tegmental area supports the possible physiological significance of this peptide-catecholamine interaction.

References (43)

  • UhlG.R. et al.

    Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: immunohistochemical mapping

    Brain Res.

    (1979)
  • WagnerJ. et al.

    Determination of DOPA, dopamine, DOPAC, epinephrine, norepinephrine, α-monofluoromethyldopa and α-difluoromethyldopa in various tissues of mice and rats using reversed-phase ion-par liquid chromatography with electrochemical detection

    J. Chromat.

    (1979)
  • YoungW.S. et al.

    Neurotensin receptor localization by light-microscopic autoradiography in rat brain

    Brain Res.

    (1981)
  • AndradeR. et al.

    Neurotensin selectively activates dopaminergic neurons in the substantia nigra

    Soc. Neurosci. Abs

    (1981)
  • BergerP.A. et al.

    Neuroregulators and schizophrenia

  • BozarthM.A. et al.

    Intracranial self-administration of morphine into the ventral tegmental area

    Life Sci.

    (1978)
  • BreeseG.R. et al.

    Role of monoamine neural pathways in d-amphetamine and methylphenidate-induced locomotor activity

  • BroekkampC.L.E. et al.

    Stimulant effects of enkephalin microinjection into the dopaminergic A10 area

    Nature, Lond.

    (1979)
  • CarrawayR. et al.

    The amino acid sequence of a hypothalamic peptide, neurotensin

    J. biol. Chem.

    (1975)
  • CrowT.J.. et al.

    Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process

    Life Sci.

    (1978)
  • CuelloA.C. et al.

    Substance P containing and cholinergic projections from the habenula

    Brain Res.

    (1978)
  • Cited by (194)

    • Neurotensin in reward processes

      2020, Neuropharmacology
    • Determination of neurotensin projections to the ventral tegmental area in mice

      2018, Neuropeptides
      Citation Excerpt :

      Intriguingly, many of these behavioral effects are specific to the VTA because Nts administration outside of the VTA elicits different effects. For example, while Nts injection in the VTA increases locomotor activity and DA release, intra-NA or central Nts decreases locomotor activity and does not alter DA release (Elliott et al., 1986; Kalivas et al., 1983, 1984; Meisenberg and Simmons, 1985; Vadnie et al., 2014; van Wimersma Greidanus et al., 1984). Similarly, intra-VTA Nts does not alter acute locomotor response to psychostimulants (Elliott and Nemeroff, 1986), whereas ICV or intra-NA Nts reduces psychostimulant or DA-induced hyperactivity (Ervin et al., 1981; Jolicoeur et al., 1985; Nemeroff et al., 1983; Sarhan et al., 1997; Skoog et al., 1986).

    • Substance P and neurotensin in the limbic system: Their roles in reinforcement and memory consolidation

      2018, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      The summary of central effects of NT can be seen in Table 2. NT microinjection into the VTA causes hyperactivity, i.e. increases locomotion, rearing and sniffing, additionally, it decreases sleep and resting (Kalivas et al., 1983; Kalivas et al., 1981). NT by itself does not influence the general activity in the NAC (Kalivas et al., 1983) and in the VP (Ollmann et al., 2015b; Torregrossa and Kalivas, 2008), however, it shows a tendency to increase cocaine-induced locomotion (Torregrossa and Kalivas, 2008).

    View all citing articles on Scopus
    View full text